Victoria Niklas's most recent trade in FibroBiologics Inc was a trade of 30,803 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroBiologics Inc | Victoria Niklas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 30,803 | 30,803 | - | - | Stock Option (Right to Buy) | |
| FibroBiologics Inc | Victoria Niklas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| FibroBiologics Inc | Victoria Niklas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |